UNSPSC 51362800: Hypnotic quinazolines

Hypnotic drugs made from benzopyrimidines, or compounds consisting of two six-membered rings, one benzene, one pyrimidine ring.

UNSPSC 51362800 Hypnotic quinazolines is a Class code with little recent state and local procurement activity aligned to its nominal scope. The three most recent opportunities posted under this code—Seminole County's naloxone and drug deactivation systems procurement, Texas HHS's therapeutic pharmacy initiative RFI, and Minnesota's generic multi-source pharmaceuticals cooperative purchasing agreement—address pharmaceutical supply and emergency-response medical products but do not reflect hypnotic quinazoline purchasing patterns. State and local governments do source pharmaceuticals through state health departments, county community health agencies, cooperative purchasing alliances, and county procurement offices, typically via RFP or cooperative-purchasing vehicles with wholesalers and manufacturers. The issuing bodies span state-level health agencies (Texas HHS, Minnesota Department of Administration), county health departments (Seminole County, Florida), and multistate cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance), but the recent solicitations show no exclusive demand for hypnotic quinazolines specifically.

Geographic activity appears concentrated in Florida, Texas, and Minnesota based on recent postings. The Seminole County opportunity (IFB60459723LAS, due July 26, 2023) seeks annual supply of 1,900 units of naloxone and 800 drug deactivation systems with quarterly deliveries to Sanford; the Texas HHS RFI (HHS0017013, posted April 3, 2026) explores direct-to-manufacturer prescription fulfillment capabilities; and the Minnesota cooperative purchasing RFP (S1070000015802, due March 26, 2026) establishes contracts for generic pharmaceuticals and OTC products across participating state and local facilities including Oregon. The code shows no pattern of sustained demand for hypnotic quinazolines as a category. Vendors considering this code should investigate whether recent tagging reflects a data-classification error or whether state and local agencies are procuring this drug class under a different UNSPSC code, as current activity does not support a pursue decision.